FOLH1 and neoplasm: The same held true for [177Lu]Lu-Ibu-DAB-PSMA in PC-3 PIP tumor-bearing mice; however, in this setting, [177Lu]Lu-PSMA-617 showed more favorable tumor-to-blood ratios early after injection of the high molar ligand amount.